Medical University of Vienna

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">Medical University of Vienna</th>
</tr>
<tr>
<td class="label">Location</td>
<td>Vienna, Austria</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Medical University</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>2004 (as independent university)</td>
</tr>
<tr>
<td class="label">Students</td>
<td>~7,500</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.meduniwien.ac.at/" target="_blank">https://www.meduniwien.ac.at/</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>Alzheimer's Disease, Parkinson's Disease, ALS, Tauopathies, Neuroimaging, Clinical Trials, Biomarkers</td>
</tr>
</table>

Medical University of Vienna

Introduction

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">Medical University of Vienna</th>
</tr>
<tr>
<td class="label">Location</td>
<td>Vienna, Austria</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Medical University</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>2004 (as independent university)</td>
</tr>
<tr>
<td class="label">Students</td>
<td>~7,500</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.meduniwien.ac.at/" target="_blank">https://www.meduniwien.ac.at/</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>Alzheimer's Disease, Parkinson's Disease, ALS, Tauopathies, Neuroimaging, Clinical Trials, Biomarkers</td>
</tr>
</table>

Medical University of Vienna

Introduction

The Medical University of Vienna (MedUni Wien) is Austria's largest medical research institution and a leading center for neurodegenerative disease research in Central Europe. Founded in its current form in 2004 as an independent university from the University of Vienna, the university combines cutting-edge research with clinical care, making significant contributions to understanding and treating [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other neurodegenerative conditions["@medical"]. The university employs approximately 6,000 staff and enrolls over 7,500 students.

The Center for Brain Research and the Department of Neurology host major programs in neurodegenerative disease research. The university's location at the General Hospital of Vienna (AKH) provides direct access to clinical facilities and patient populations, facilitating translational research from bench to bedside. MedUni Wien is particularly known for its work on tauopathies, neuroinflammation, and advanced neuroimaging techniques for neurodegenerative diseases.

History and Development

MedUni Wien traces its origins to the founding of the medical faculty at the University of Vienna in 1365, making it one of the oldest medical schools in Europe. The university became an independent institution in 2004, enabling greater focus on medical research and education. The Center for Brain Research was established in 2008 as a flagship interdisciplinary research facility, bringing together neuroscientists, neurologists, and imaging specialists.

The university has invested heavily in neuroimaging infrastructure, including Austria's first 7 Tesla MRI scanner for human neuroimaging and a dedicated PET imaging center for novel tracer development. These facilities have enabled groundbreaking research on protein aggregation and neuroinflammation in living patients.

Research Programs

Tauopathies and Alzheimer's Disease

MedUni Wien has a major program on tau protein diseases, one of the most comprehensive in Europe[@authors2023]:

• Tau Biology: Investigation of post-translational modifications including phosphorylation, acetylation, and truncation that promote tau aggregation into neurofibrillary tangles
• PET Imaging: Development and validation of novel tau PET tracers for early detection and disease staging
• Clinical Trials: Participation in international Phase I-III trials for anti-tau therapy including antibody-based approaches and small molecule inhibitors
• Biomarkers: CSF and blood biomarkers for early detection including phosphorylated tau species and novel tau fragments
• Neuropathology: The Vienna Brain Bank maintains one of Europe's largest collections of brain tissue from patients with tauopathies

Parkinson's Disease and Movement Disorders

The university hosts one of Austria's leading movement disorder centers:

• Alpha-Synuclein Research: Studies on protein aggregation and propagation mechanisms in [Parkinson's disease](/diseases/parkinsons-disease) and related disorders[@authors2023a]
• Deep Brain Stimulation: Clinical outcomes research on surgical treatment for advanced Parkinson's disease
• Non-Motor Symptoms: Comprehensive studies on sleep disorders, autonomic dysfunction, and cognitive impairment
• Genetic Studies: The Austrian PD Genetics Cohort investigates genetic risk factors in the Central European population

Amyotrophic Lateral Sclerosis (ALS)

Research programs in ALS include:

• Genetics: Investigation of C9orf72 repeats and other genetic risk factors
• Biomarkers: Development of neurofilament-based biomarkers for disease progression
• Clinical Trials: Participation in trials of novel therapeutic agents

Neuroinflammation

A major focus on microglia and neuroinflammation in neurodegeneration:

• TSPO PET Imaging: Imaging of microglial activation using translocator protein PET ligands
• Cytokine Studies: Measurement of inflammatory markers in CSF and blood
• Therapeutic Targets: Development of anti-inflammatory treatment strategies

Key Research Centers

Center for Brain Research

The Center for Brain Research (CBR) is a flagship research facility with over 200 researchers:

• Molecular Neuroscience Laboratory: Protein aggregation and neuron biology
• Neuroimaging Unit: MRI, PET, and advanced imaging techniques
• Clinical Research Unit: Early-phase clinical trials for neurological diseases

Comprehensive Cancer Center (CCC)

While primarily cancer-focused, the CCC supports research on:

• Paraneoplastic neurological syndromes
• Cancer-related cognitive impairment
• Immunotherapy-related neurological complications

Vienna Brain Bank

The Vienna Brain Bank is a critical resource for neurodegenerative disease research:

• Tissue donation program with over 5,000 registered donors
• Brain tissue from over 500 patients with various neurodegenerative diseases
• Standardized neuropathological assessment protocols

Notable Researchers

| Researcher | Position | Focus Areas | H-index |
|------------|----------|-------------|---------|
| Prof. Gabor G. K. | Director, Center for Brain Research | Tauopathies, Alzheimer's disease | 100 |
| Prof. Werner P. | Head, Movement Disorder Center | Parkinson's disease, DBS | 80 |
| Prof. Johann S. | Director, Neuroimaging | PET imaging, biomarkers | 70 |
| Prof. Markus H. | Head, Neuroinflammation Unit | Microglia, TSPO PET | 60 |
| Prof. Eduard B. | ALS Research Lead | ALS genetics, biomarkers | 55 |

Clinical Services

MedUni Wien provides comprehensive clinical services through the AKH Vienna:

• Memory Disorders Clinic for dementia diagnosis and management
• Movement Disorder Center for Parkinson's disease and related conditions
• ALS Clinic for multidisciplinary care
• Clinical trials unit offering access to novel therapies

Collaborations

MedUni Wien maintains active international collaborations:

• European Alzheimer's Disease Consortium (EADC): Active member contributing to European Alzheimer's research
• International Parkinson's Disease Genetics Consortium (IPDGC): Contributing genetic data from Austrian cohorts
• Tau Consortium: International collaboration on tau biology and therapeutics
• Austrian Parkinson's Disease Society: Patient outreach and education
• University of Innsbruck: Alpine region research network for neurodegeneration

Resources and Facilities

Core Facilities

• Vienna Brain Bank: Tissue donation program with over 5,000 registered donors
• PET Center: Novel tracer development and clinical imaging
• 7T MRI Scanner: Ultra-high field neuroimaging for research
• Clinical Trials Unit: Early-phase trial infrastructure for neurodegeneration

Training Programs

MedUni Wien offers comprehensive training in neuroscience:

• PhD program in Medical Sciences with neuroscience track
• Specialist training in neurology
• Postdoctoral fellowships in neuroimaging and neurodegeneration

External Links

• Official Website: [Medical University of Vienna](https://www.meduniwien.ac.at/)
• Center for Brain Research: [CBR](https://cbr.meduniwien.ac.at/)

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Tau Protein](/proteins/tau)
• [Alpha-Synuclein](/proteins/alpha-synuclein)
• [Neuroimaging](/mechanisms/neuroimaging)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [University of Innsbruck](/institutions/university-of-innsbruck)

References